Tag: SPL

Starpharma ASX SPL pancreatic cancer DEP irinotecan oncological diseases clinical trials

Starpharma’s DEP irinotecan candidate has positive impact on human pancreatic cancer in mice

Starpharma (ASX: SPL) reported its DEP irinotecan candidate has induced “complete tumour regression” when trialled on mouse xenograft models with human pancreatic cancer. During the study, when Sta...
Read more
Starpharma Agrochemicals ASX SPL Agrium

Starpharma sells Agrochemicals business to Agrium for $35M

Starpharma Holdings (ASX: SPL) has completed a transaction to sell its agrochemicals and Priostar® business (Starpharma Agrochemicals) to Agrium, Inc. (NYSE: AGU, TSE: AGU) for A$35 million in cash co...
Read more

RECENT POSTS

STOCK SUMMARY

INVESTOR TOOLS

FOLLOW US

HOT TOPICS

TRENDING POSTS

Small Caps ASX Australian stock market
Small Caps is Australia's #1 site for news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
Copyright 2020 Small Caps. All rights reserved.